X. Zhang et al. / Tetrahedron 67 (2011) 8790e8799
8797
CDCl3):
d
¼6.92 (m, 2H), 6.77 (m, 2H), 3.59 (br, 2H), 3.38 (br, 2H),
CDCl3):
4H), 6.93 (d, 1H), 3.88 (br, 2H), 3.63 (br, 2H), 1.19e1.17 (d, 12H). 13C
NMR (100 MHz, CDCl3):
d
¼8.08e8.06 (d, 1H), 7.80e7.78 (d, Hz, 1H), 7.47e7.35 (m,
1.99e1.03(m, 20H). 13C NMR (100 MHz, CDCl3):
d¼150.6, 124.9,
124.8, 116.1, 115.9, 50.4, 34.0, 25.9, 25.2.
d¼150.2, 147.1, 135.1, 129.9, 128.1, 126.8,
126.1, 125.0, 124.7, 121.7, 118.1, 43.6, 23.7.
4.5.4. N-o-Chlorophenyl-N0,N00-diisopropylguanidine (5)11. Product 5
was obtained following the procedure 1 catalyzed by catalysts III
and isolated as a white solid in 95% yield. 1H NMR (400 MHz,
CDCl3):
3.79 (br, 2H), 3.48 (br, 2H), 1.19e1.17 (12H). 13C NMR (100 MHz,
CDCl3):
¼150.1, 147.2, 130.1, 128.5, 127.8, 125.5, 122.7, 43.6, 23.6.
4.5.13. N,N00-Diisopropyl-N0-2,6-diisopropylphenylguanidine (14)7b
.
Product 14 was obtained following the procedure 1 catalyzed by
d
¼7.35e7.33 (m, 1H), 7.15e7.11(m, 1H), 6.91e6.85 (m, 2H),
catalysts III and isolated as a white solid in 97% yield. 1H NMR
(400 MHz, CDCl3):
d
¼7.07e7.05 (d, 2H), 6.98e6.94 (m, 1H), 4.19 (br,
d
1H), 3.43e3.19 (br, 3H), 3.11e3.04 (m, 2H), 1.25e1.04 (m, 24H). 13C
NMR (100 MHz, CDCl3):
42.7, 28.0, 23.9.
d
¼147.7, 144.3, 141.6, 123.2, 122.3, 43.5,
4.5.5. N-o-Chlorophenyl-N0,N00-dicyclohexylguanidine (6)11. Product
6 was obtained following the procedure 1 catalyzed by catalysts III
and isolated as a white solid in 94% yield. 1H NMR (400 MHz,
CDCl3):
3.56 (br, 2H), 3.42 (br, 2H), 2.05e1.06 (m, 20H). 13C NMR (100 MHz,
CDCl3):
4.5.14. N-Butyl-N0,N00-diisopropylguanidine (15)11. Product 15 was
obtained following the procedure 2 catalyzed by catalysts III
d
¼7.34e7.33 (m, 1H), 7.15e7.11 (m, 1H), 6.92e6.85 (m, 2H),
and isolated as
(400 MHz, CDCl3):
a
colorless liquid in 96% yield. 1H NMR
d
¼150.1, 147.6, 130.1, 128.7, 127.8, 125.6, 122.6, 50.5, 34.1,
d
¼3.57e3.48 (m, 2H), 3.05e2.98 (m, 2H),
26.0, 25.2.
1.53e1.48 (m, 2H), 1.42e1.34 (m, 2H), 1.15e1.07 (d, 12H), 0.93 (t,
3H). 13C NMR (100 MHz, CDCl3):
21.2, 14.7.
d
¼151.8, 44.7, 34.0, 33.7, 24.6,
4.5.6. N-o-Methylphenyl-N0,N00-diisopropylguanidine (7)7b. Product
7 was obtained following the procedure 1 catalyzed by catalysts III
and isolated as a white solid in 90% yield. 1H NMR (400 MHz,
4.5.15. N,N0-Diisopropylpyrrolidine-1-carboximidamide (16)11. Pro-
duct 16 was obtained following the procedure 1 catalyzed by cat-
alysts III and isolated as a colorless liquid in 98% yield. 1H NMR
CDCl3):
d
¼7.15 (d, 1H), 7.09 (m, 1H), 6.90e6.86(m, 1H), 6.78 (d, 1H),
3.76 (br, 2H), 3.46 (br, 2H), 2.14 (s, 3H), 1.17 (d, 12H). 13C NMR
(100 MHz, CDCl3):
43.4, 23.7, 18.4.
d
¼149.1, 148.6, 131.8, 130.6, 126.8, 123.4, 121.9,
(400 MHz, CDCl3):
d
¼3.38 (m, 2H), 3.26 (m, 4H), 1.80 (m, 4H),
1.11 (d, 12H). 13C NMR (100 MHz, CDCl3):
26.3, 24.8.
d
¼153.7, 47.9, 46.8,
4.5.7. N-o-Methylphenyl-N0,N00-dicyclohexylguanidine (8)7b. Product
8 was obtained following the procedure 1 catalyzed by catalysts III
and isolated as a white solid in 91% yield. 1H NMR (400 MHz,
4.5.16. N,N0-Dicyclohexylpyrrolidine-1-carboximidamide (17)11. Pro-
duct 17 was obtained following the procedure 1 catalyzed by cat-
alysts III and isolated as a white solid in 96% yield. 1H NMR
CDCl3):
d
¼6.93 (m, 2H), 6.78 (m, 2H), 3.62 (br, 2H), 3.40 (br, 2H),
2.00(s, 3H), 1.97e1.03 (m, 20H). 13C NMR (100 MHz, CDCl3):
(400 MHz, CDCl3):
d
¼3.21(m, 4H), 2.89 (m, 2H), 1.75e1.08 (m, 24H).
d
¼148.9, 148.7, 131.9, 130.6, 126.8, 123.5, 121.9, 50.4, 34.2, 25.9, 25.2,
13C NMR (100 MHz, CDCl3):
25.5.
d¼154.0, 55.3, 48.3, 35.4, 26.0, 25.9,
18.4.
4.5.8. N-o-Methoxyphenyl-N0,N00-diisopropylguanidine (9)9b. Product
9 was obtained following the procedure 1 catalyzed by catalysts III
and isolated as a white solid in 98% yield. 1H NMR (400 MHz, CDCl3):
4.5.17. N,N0-Diisopropylpiperidine-1-carboximidamide (18)11. Product
18 was obtained following the procedure 2 catalyzed by catalysts I
and isolated as a colorless liquid in 93% yield. 1H NMR (400 MHz,
d
¼6.94e6.86(m, 4H), 3.78 (m, 5H), 3.56 (br, 2H), 1.17e1.15 (d, 12H).
CDCl3):
d
¼3.40e3.30 (m, 2H), 3.03 (s, 4H), 1.53 (s, 6H), 1.10 (d,
13C NMR (100 MHz, CDCl3):
111.8, 55.6, 43.3, 23.4.
d
¼152.4, 150.7, 139.2, 124.7, 122.2, 121.3,
12H). 13C NMR (100 MHz, CDCl3):
24.8, 24.0.
d
¼156.3, 49.2, 46.6, 45.7, 26.3,
4.5.9. N-o-Methoxyphenyl-N0,N00-dicyclohexylguanidine (10)11. Product
10 was obtained following the procedure 1 catalyzed by catalysts III
and isolated as a white solid in 92% yield. 1H NMR (400 MHz, CDCl3):
4.5.18. N,N0-Dicyclohexylpiperidine-1-carboximidamide (19)11. Product
19 was obtained following the procedure 1 catalyzed by catalysts III
and isolated as a white solid in 96% yield. 1H NMR (400 MHz, CDCl3):
d
¼6.96e6.85 (m, 4H), 3.79 (s, 3H), 3.60 (br, 2H), 3.45 (br, 2H),
d
¼3.02 (s, 4H), 2.87 (br, 2H), 1.90e1.05 (m, 26H). 13C NMR (100 MHz,
2.04e1.04(m, 20H). 13C NMR (100 MHz, CDCl3):
d
¼152.6, 150.5, 139.3,
CDCl3):
d¼156.0, 55.9, 53.7, 49.2, 34.9, 34.9, 26.3, 26.0, 25.7, 25.4.
125.0, 122.4, 121.4, 111.9, 55.7, 50.4, 34.0, 25.9, 25.1.
4.5.19. N,N0-Diisopropylmorpholine-4-carboximidamide (20)11. Product
20 was obtained following the procedure 1 catalyzed by catalysts III
and isolated as a white solid in 95% yield. 1H NMR (400 MHz, CDCl3):
4.5.10. N-p-Nitrophenyl-N0,N00-diisopropylguanidine (11)8. Product
11 was obtained following the procedure 1 catalyzed by catalysts III
and isolated as a yellow solid in 90% yield. 1H NMR (400 MHz,
d
¼3.69e3.67 (m, 4H), 3.42e3.39 (m, 1H), 3.32e3.29 (m, 1H),
3.08e3.06 (m, 4H), 1.14e1.06(m, 12H). 13C NMR (100 MHz, CDCl3):
¼155.5, 67.3, 48.9, 47.4, 46.6, 23.9, 23.8.
CDCl3):
d
¼8.11e8.09 (m, 2H), 6.90e6.88 (m, 2H), 3.83e3.78 (br, 4H),
1.19e1.18 (d, 12H). 13C NMR (100 MHz, CDCl3):
d
¼158.6, 150.8, 141.1,
d
125.9, 123.1, 43.7, 23.6.
4.5.20. N,N0-Dicyclohexylmorpholine-4-carboximidamide (21)8. Product
21 was obtained following the procedure 1 catalyzed by catalysts III
and isolated as a white solid in 98% yield. 1H NMR (400 MHz, CDCl3):
4.5.11. N-p-Chlorophenyl-N0,N00-diisopropylguanidine (12)3k. Product
12 was obtained following the procedure 1 catalyzed by catalysts III
and isolated as a white solid in 95% yield. 1H NMR (400 MHz, CDCl3):
d
¼3.66 (m, 4H), 3.06 (m, 4H), 2.97e2.88 (m, 2H), 1.90e1.02 (m, 20H).
d
¼7.20e7.18 (d, 2H), 6.79e6.77 (d, 2H), 3.75 (br, 2H), 3.60 (br, 2H),
13C NMR (100 MHz, CDCl3):
26.3,26.1, 25.9.
d
¼155.2, 67.5, 56.7, 54.0, 49.1, 35.6, 34.9,
1.17e1.15(d, 12H). 13C NMR (100 MHz, CDCl3):
d
¼150.5, 149.2, 129.4,
126.4, 125.1, 43.5, 23.6.
4.5.21. N-Benzyl-N-methyl-N0,N00-diisopropylguanidine (22)11. Product
22 was obtained following the procedure 1 catalyzed by catalysts III
and isolated as a colorless liquid in 97% yield. 1H NMR (400 MHz,
4.5.12. N-(1-Naphthyl)-N0,N00-diisopropylguanidine (13)8. Product
13 was obtained following the procedure 1 catalyzed by catalysts III
and isolated as a white solid in 95% yield. 1H NMR (400 MHz,
CDCl3):
d¼7.32e7.29 (m, 3H), 7.24e7.20 (m, 2H), 4.30 (s, 2H), 3.50 (br,